1. Lubomir Sokol, Mojdeh Naghashpour and L. Frank Glass. Primary Cutaneous B-Cell Lymphomas:Recent Advances in Diagnosis and Management. Cancer Control. 2012 Jul;19(3):236-44.
2. Senff NJ, Noordijk EM, Kim YH, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112(5):1600-1609.
3. Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHOEORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol. 2007;25(12):1581-1587.
4. Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol. 2000; 24(9):1279-1285. [OpenAIRE]
5. Vibha Thomas, Robin Dobson and Robert Mennel. Primary cutaneous large B-cell lymphoma, leg type. Proc (Bayl Univ Med Cent) 2011; 24(4):350-353.
6. Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B,Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E,Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, WechslerJ, Petrella T. Primary cutaneous diffuse large B-cell lymphoma, leg type:clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol 2007; 143(9):1144-1150.
7. Geelen FA, Vermeer MH, Meijer CJ, Van der Putte SC, Kerkhof E, Kluin PM, Willemze R. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 1998;16(6):2080-2085.
8. Guyot A, Ortonne N, Valeyrie-Allanore L, Bagot M. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients. Arch Dermatol. 2010 Jan;146(1):89-91 [OpenAIRE]